Digitalis Ventures is an institutional investor (Conventional VCs) founded in 2016 and headquartered in Boston, United States. Investing in breakthrough science and technology to improve human and animal health. The company invests in biotechnology and technology-enabled solutions to address unmet needs in health. They provide venture capital to early-stage companies across life sciences, health technologies, services, and animal health. Their expertise and network of entrepreneurs, technical experts, research institutions, and financial partners allow them to forge deep relationships and create lasting solutions. The company also publishes insights on human and animal health, science, and technology. They are part of a group that includes applied research and a non-profit developing public-interest technologies for better health.

Stage

pre-seed, seed, Series A, Series B, growth, pre-seed, seed, Series A, Series B, growth

Check size

$250K-$50M+

HQ

New York City, United States

Founded

2016

Website

https://www.digitalisventures.com/

LinkedIn

https://linkedin.com/company/digitalis-ventures

Twitter

https://twitter.com/digitalisvc

What they look for

US primary (Europe secondary), founders with deep domain expertise (MD, PhD, DVM preferred), breakthrough science/technology addressing unmet health needs, mission-driven multidisciplinary teams

Preparing to pitch Digitalis Ventures?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.